Biocon to sell its business undertaking relating to drug substance

03 Apr 2019 Evaluate

Biocon has received an approval for the sale and transfer of its business undertaking relating to drug substance manufactured in the GPP facility of the Company, on a going- concern basis, with effect from April 1, 2019. The Board of Directors of the company at their meeting held on April1, 2019, approved the same. 

The sale of business undertaking will be to Biocon Biologics India, a wholly owned subsidiary.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

365.25 -1.15 (-0.31%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×